Hepatic complications of parenteral nutrition in adults;Les complications hepatiques de la nutrition parenterale chez l'adulte

Nutrition Clinique et Metabolisme

Volumn 13, Issue 4, 1999, Pages 260-266

  Cavicchi, Maryan ^a   Messing, Bernard ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cholestasis; Cirrhosis; Lipids; Short bowel syndrome; Ursodeoxycholic acid

Indexed keywords

TAURINE DERIVATIVE; URSODEOXYCHOLIC ACID;

BACTERIAL OVERGROWTH; CHOLESTASIS; DISEASE ASSOCIATION; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER FIBROSIS; PARENTERAL NUTRITION; PORTAL HYPERTENSION; REVIEW; SHORT BOWEL SYNDROME;

BACTERIA (MICROORGANISMS);

EID: 0033384986     PISSN: 09850562     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0985-0562(99)80055-7     Document Type: Review

References (72)

1. Bueno J, Ohwada S, Kocoshis S, Mazariegos GV, Dvorchik I, Sigurdsson L, et al. Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg 1999 ; 34 : 27-33.
2. Grant D. Current results of intestinal transplantation. The international intestinal transplant registry. Lancet 1996 ; 347 : 1801-3.
3. Bowyer BA, Fleming CR, Ludwig J, Petz J, McGill DB. Does long-term home parenteral nutrition in adult patients cause chronic liver disease ? JPEN J Parenter Enteral Nutr 1985 ; 9 : 11-7.
4. Cano N, Messing B. Conséquences hépatiques et biliaires de la nutrition artificielle. Nutr Clin Métabol 1994 ; 8 : 149-62.
5. Clarke PJ, Ball MJ, Kettlewell MG. Liver function tests in patients receiving parenteral nutrition. JPEN J Parenter Enteral Nutr 1991 ; 15 : 54-9.
6. Ito Y, Shils ME. Liver dysfunction associated with long-term total parenteral nutrition in patients with massive bowel resection. JPEN J Parenter Enteral Nutr 1991 ; 15 : 271-6.
7. Messing B, Colombel JF, Heresbach D, Chazouillères O, Galian A. Chronic cholestasis and macronutrient excess in patients treated with prolonged parenteral nutrition. Nutrition 1992 ; 8 : 30-6.
8. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993 ; 104 : 286-301.
9. Sax HC, Bower RH. Hepatic complications of total parenteral nutrition. JPEN J Parenter Enteral Nutr 1988 ; 12 : 615-8.
10. Nanji AA, Anderson FH. Cholestasis associated with parenteral nutrition develops more commonly with hematological malignancy than with inflammatory bowel disease [letter]. JPEN J Parenter Enteral Nutr 1984 ; 8 : 325.
11. Bengoa JM, Hanauer SB, Sitrin MD, Baker AL, Rosenberg IH. Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease. Hepatology 1985 ; 5 : 79-84.
12. Messing B, Zarka Y, Lemann M, Iglicki F, Coffin B, Rambaud J. Chronic cholestasis associated with long-term parenteral nutrition. Transplant Proc 1994 ; 26 : 1438-9.
13. Beau P, Chammartin F, Matuchansky C. Anomalies biologiques hépatiques, ictères cholestatiques et nutrition artificielle à l'hôpital. Gastroenterol Clin Biol 1988 ; 12 : 326-31.
14. Craig RM, Neumann T, Jeejeebhoy KN, Yokoo H. Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology 1980 ; 79 : 131-7.
15. Cavicchi M, Crenn P, Beau P, Degott C, Boutron M, Messing B. Severe liver complication associated with long-term parenteral nutrition are dependent on lipid parenteral input [abstract]. Gastroenterology 1997 ; 112 : A864.
16. Dahms BB, Halpin TC, Jr. Serial liver biopsies in parenteral nutrition-associated cholestasis of early infancy. Gastroenterology 1981 ; 81 : 136-44.
17. Stanko RT, Nathan G, Mendelow H, Adibi SA. Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition. Gastroenterology 1987 ; 92 : 197-202.
18. Stokes MA, Irving MH. Mortality in patients on home parenteral nutrition. JPEN J Parenter Enteral Nutr 1989 ; 13 : 172-5.
19. Messing B, Lemann M, Landais P, Gouttebel MC, Gerard-Boncompain M, Saudin F, et al. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology 1995 ; 108 : 1005-10.
20. Burnes JU, Fleming CR, Devine RM, Berkner S, Herrick L. Home parenteral nutrition - a 3-year analysis of clinical and laboratory monitoring. JPEN J Parenter Enteral Nutr 1992 ; 16 : 327-32.
21. Mughal M, Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet 1986 ; 2 : 383-7.
22. Drongowski RA, Coran AG. An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis. JPEN J Parenter Enteral Nutr 1989 ; 13 : 586-9.
23. Fouin-Fortunet H, Hemet J, Ducastelle T, Galmiche JP, Lerebours E, Colin R. Altérations hépatiques au cours de la nutrition parentérale exclusive prolongée dans les entérocolites cryptogénétiques. Étude clinique, histologique et ultra-structurale. Gastroenterol Clin Biol 1981 ; 5 : 145-54.
24. Fouin-Fortunet H, Le Quernec L, Erlinger S, Lerebours E, Colin R. Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease: a possible consequence of lithocholate toxicity. Gastroenterology 1982 ; 82 : 932-7.
25. Messing B, de Oliveira FJ, Galian A, Bernier JJ. Cholestase au cours de la nutrition parentérale totale : mise en évidence de facteurs favorisants; association à une lithiase vésiculaire. Gastroenterol Clin Biol 1982 ; 6 : 740-7.
26. Wolfe BM, Walker BK, Shaul DB, Wong E, Ruebner BH. Effect of total parenteral nutrition on hepatic histology. Arch Surg 1988 ; 123 : 1084-90.
27. Beau P, Barrioz T, Ingrand P. L'hépatopathie cholestatique de la nutrition parentérale totale est-elle une maladie infectieuse ? Gastroenterol Clin Biol 1994 ; 18 : 63-7.
28. van Deventer SJ, ten Cate JW, Tytgat GN. Intestinal endotoxemia. Clinical significance. Gastroenterology 1988 ; 94 : 825-31.
29. Kono K, Ohnishi K, Omata M, Saito M, Nakayama T, Hatano H, et al. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology 1988 ; 94 : 787-96.
30. Capron JP, Gineston JL, Herve MA, Braillon A. Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet 1983 ; 1 : 446-7.
31. Lambert JR, Thomas SM. Metronidazole prevention of serum liver enzyme abnormalities during total parenteral nutrition. JPEN J Parenter Enteral Nutr 1985 ; 9 : 501-3.
32. Ferezou J, Beau P, Parquet M, Champarnaud G, Lutton C, Matuchansky C. Cholesterol and bile acid biodynamics after total small bowel resection and bile diversion in humans. Gastroenterology 1993 ; 104 : 1786-95.
33. Levecq H, Lageron A, Gotheil C, Callard P, Beaugrand M. Etude de la surcharge lipidique hépatique au cours de deux cas de cholestase associée à la nutrition parentérale. Gastroenterol Clin Biol 1988 ; 12 : 691-6.
34. Wagner WH, Lowry AC, Silberman H. Similar liver function abnormalities occur in patients receiving glucose-based and lipid-based parenteral nutrition. Am J Gastroenterol 1983 ; 78 : 199-202.
35. Degott C, Messing B, Moreau D, Chazouillères O, Paris R, Colombel JF, et al. Liver phospholipidosis induced by parenteral nutrition: histologic, histochemical, and ultrastructural investigations. Gastroenterology 1988 ; 95 : 183-91.
36. Kaminski DL, Adams A, Jellinek M. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery 1980 ; 88 : 93-100.
37. Martinez M, Ballabriga A. Effects of parenteral nutrition with high doses of linoleate on the developing human liver and brain. Lipids 1987 ; 22 : 133-8.
38. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993 ; 105 : 1806-13.
39. Fischer GW, Hunter KW, Wilson SR, Mease AD. Diminished bacterial defenses with intralipid. Lancet 1980 ; 2 : 819-20.
40. Roth B, Fkelund M, Fan BG, Hagerstrand I, Nilsson-Ehle P. Lipid deposition in Kupffer cells after parenteral fat nutrition in rats: a biochemical and ultrastructural study. Intensive Care Med 1996 ; 22 : 1224-31.
41. Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, van Deemter L, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993 ; 75 : 451-62.
42. Forbush B, Kiristioglu I, Teitelbaum D, Eisenbraun M, Heidelberg K. Multi drug resistance 2 gene expression in the murine liver: relevance to the development of parenteral nutrition-associated cholestasis [abstract]. Gastroenterology 1998 ; 114 : L0 173.
43. Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997 ; 113 : 255-64.
44. Van Gossum A. Aspects spécifiques de la nutrition artificielle à domicile. In : Leverve X, Cosnes J, Erny P, Hasselmann M, eds. Traité de nutrition artificielle de l'adulte. Paris : Mariette Guéna ; 1998. p. 559-80.
45. Goulet O, de Potter S, Antebi H, Driss F, Colomb V, Bereziat G, et al. Long-term efficacy and safety of a new olive oil-based intravenous fat emulsion in pediatric patients: a double-blind randomized study. Am J Clin Nutr 1999 ; 70 : 338-45.
46. Redmond HP, Stapleton PP, Neary P, Bouchier-Hayes D. Immunonutrition: the role of taurine. Nutrition 1998 ; 14 : 599-604.
47. Yoh SL, Chang KY, Huang PC, Chen WJ. Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Nutrition 1997 ; 13 : 32-6.
48. Alexander JW. Immunonutrition: the role of omega-3 fatty acids. Nutrition 1998 ; 14 : 627-33.
49. Hayashi N, Tashiro T, Yamamori H, Takagi K, Morishima Y, Otsubo Y, et al. Effects of intravenous omega-3 and omega-6 fat emulsion on cytokine production and delayed type hypersensitivity in burned rats receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr 1998 ; 22 : 363-7.
50. Van Aerde JE, Duerksen DR, Gramlich L, Meddings JB, Chan G, Thomson AB, et al. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr Res 1999 ; 45 : 202-8.
51. Belli DC, Fournier LA, Lepage G, Yousef I, Weber AM, Tuchweber B, et al. Total parenteral nutrition-associated cholestasis in rats: comparison of different amino acid mixtures. JPEN J Parenter Enteral Nutr 1987 ; 11 : 67-73.
52. Guertin F, Roy CC, Lepage G, Perea A, Giguere R, Yousef I, et al. Effect of taurine on total parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 1991 ; 15 : 247-51.
53. Seabra V, Stachlewitz RF, Thurman RG. Taurine blunts LPS-induced increase in intracellular calcium and TNF- alpha production by Kupffer cells. J Leukocyt Biol 1998 ; 64 : 615-21.
54. Demircan M, Ergun O, Coker C, Yilmaz F, Avanoglu S, Ozok G. Aluminum in total parenteral nutrition solutions produces portal inflammation in rats. J Pediatr Gastroenterol Nutr 1998 ; 26 : 274-8.
55. Berger HM. The pathogenesis of cholestasis in parenteral nutrition [letter]. JPEN J Parenter Enteral Nutr 1985 ; 9 : 524-5.
56. Van Nieuwkerk CM, Elferink RF, Groen AK, Ottenhoff R, Tytgat GN, Dingemans KP, et al. Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1996 ; 111 : 165-71.
57. Duerksen DR, Van Aerde JE, Gramlich L, Meddings JB, Chan G, Thomson AB, et al. Intravenous ursodeoxycholic acid reduces cholestasis in parenteraly fed newborn piglets. Gastroenterology 1996 ; 111 : 1111-7.
58. Beau P, Labat-Labourdette J, Ingrand P, Beauchant M. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? J Hepatol 1994 ; 20 : 240-4.
59. Spagnuolo MI, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology 1996 ; 111 : 716-9.
60. Levy S, Capron JP, Erlinger S. Mécanisme d'action de l'acide ursodésoxycholique dans les maladies cholestatiques du foie. Gastroenterol Clin Biol 1996 ; 20 : 549-59.
61. Cavicchi M, Beau P, Messing B. Benefit of the treatment by ursodeoxycholic acid and taurine for chronic cholestasis associated with long-term parenteral nutrition [abstract]. Gastroenterology 1998 ; 114 : G3567.
62. Ono T, Imai K, Kohno H, Uchida M, Takemoto Y, Dhar DK, et al. Tauroursodeoxycholic acid protects cholestasis in rat reperfused livers: its roles in hepatic calcium mobilization. Dig Dis Sci 1998 ; 43 : 2201-10.
63. Demircan M, Ugaralp S, Mutus M, Gurer El, Atik E, Turhan F, et al. The effects of acetylsalicylic acid, interferon-alpha, and vitamin E on prevention of parenteral nutrition-associated cholestasis: an experimental study. J Pediatr Gastroenterol Nutr 1999 ; 28 : 291-5.
64. Campillo B, Bories PN, Pornin B, Devanlay M. Influence of liver failure, ascites, and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis. Nutrition 1997 ; 13 : 613-21.
65. Fan ST, Wong J. Metabolic clearance of a fat emulsion containing medium-chain triglycerides in cirrhotic patients. JPEN J Parenter Enteral Nutr 1992 ; 16 : 279-83.
66. Druml W, Fischer M, Ratheiser K. Use of intravenous lipids in critically ill patients with sepsis without and with hepatic failure. JPEN J Parenter Enteral Nutr 1998 ; 22 : 217-23.
67. Druml W, Fischer M, Pidlcli J, Lenz K. Fat elimination in chronic hepatic failure: long-chain vs medium-chain triglycerides. Am J Clin Nutr 1995 ; 61 : 812-7.
68. Reilly J, Mehta R, Teperman E, Cemaj S, Tzakis A, Yanaga K, et al. Nutritional support after liver transplantation: a randomized prospective study. JPEN J Parenter Enteral Nutr 1990 ; 14 : 386-91
69. Fabbri A, Magrini N, Bianchi G, Zoli M, Marchesini G. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. JPEN J Parenter Enteral Nutr 1996 ; 20 : 159-64.
70. Chalasani N, Gitun N. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids. Am J Gastroenterol 1996 ; 91 : 1266-8.
71. Ichida T, Shibasaki K, Muto Y, Satoh S, Watanabe A, Ichida F. Clinical study of an enterai branched-chain amino acid solution in decompensated liver cirrhosis with hepatic encephalopathy. Nutrition 1995 ; 11 : 238-44.
72. Mehta PL, Alaka KJ, Filo RS, Leapman SB, Milgrom ML, Pescovitz MD. Nutrition support following liver transplantation: comparison of jejunal versus parenteral routes. Clin Transplant 1995 ; 9 : 364-9.